PPA
NBP

Parametric Portfolio Associates’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Parametric Portfolio Associates’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$993K Buy
61,167
+36,385
+147% +$932K ﹤0.01% 2788
2021
Q4 		$1.17M Sell
24,782
-7,255
-23% -$435K ﹤0.01% 2711
2021
Q3 		$2.32M Buy
32,037
+16,978
+113% +$1.23M ﹤0.01% 2356
2021
Q2 		$1.26M Buy
+15,059
New +$993K ﹤0.01% 2666

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parametric Portfolio Associates's NBP Position: Q1 2022 in Review

Parametric Portfolio Associates increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 147% in Q1 2022, buying an estimated $932K and bringing the position to 61,167 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Parametric Portfolio Associates first reported a position in NBP in Q2 2021 and has held it in 4 quarters since. The position peaked at $2.32M in Q3 2021. 119 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Parametric Portfolio Associates held 61,167 shares of NovaBridge Biosciences American Depositary Shares worth $993K as of Q1 2022.
  • Parametric Portfolio Associates bought 36,385 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $932K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2788 holding.
  • Parametric Portfolio Associates first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's NovaBridge Biosciences American Depositary Shares position peaked at $2.32M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.